Doximity (NASDAQ:DOCS) Coverage Initiated at Mizuho

Mizuho initiated coverage on shares of Doximity (NASDAQ:DOCS) in a research note released on Wednesday, MarketBeat.com reports. The brokerage issued a neutral rating and a $55.00 target price on the stock.

Several other equities analysts also recently issued reports on DOCS. Needham & Company LLC raised shares of Doximity from a “hold” rating to a “buy” rating and set a $38.00 price target for the company in a report on Friday, August 9th. Bank of America increased their price objective on shares of Doximity from $32.00 to $45.00 and gave the stock a “neutral” rating in a report on Monday, October 7th. Wells Fargo & Company raised shares of Doximity from an “underweight” rating to an “equal weight” rating and increased their price objective for the stock from $19.00 to $41.00 in a report on Friday, November 8th. KeyCorp raised shares of Doximity from a “sector weight” rating to an “overweight” rating and set a $70.00 price objective on the stock in a report on Friday, November 8th. Finally, The Goldman Sachs Group started coverage on shares of Doximity in a report on Friday, November 15th. They set a “neutral” rating and a $58.00 price objective on the stock. Twelve research analysts have rated the stock with a hold rating, six have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $52.44.

Doximity Price Performance

Shares of DOCS stock opened at $54.20 on Wednesday. Doximity has a 12-month low of $22.96 and a 12-month high of $61.75. The company has a market capitalization of $10.12 billion, a P/E ratio of 62.30, a P/E/G ratio of 4.28 and a beta of 1.40. The firm has a 50-day moving average price of $46.36 and a 200 day moving average price of $36.57.

Hedge Funds Weigh In On Doximity

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. MetLife Investment Management LLC boosted its holdings in Doximity by 0.6% during the third quarter. MetLife Investment Management LLC now owns 65,064 shares of the company’s stock worth $2,835,000 after buying an additional 363 shares during the last quarter. First Horizon Advisors Inc. boosted its holdings in Doximity by 22.5% during the third quarter. First Horizon Advisors Inc. now owns 2,094 shares of the company’s stock worth $91,000 after buying an additional 384 shares during the last quarter. GAMMA Investing LLC boosted its holdings in Doximity by 40.1% during the third quarter. GAMMA Investing LLC now owns 1,439 shares of the company’s stock worth $63,000 after buying an additional 412 shares during the last quarter. Van ECK Associates Corp boosted its holdings in Doximity by 19.7% during the second quarter. Van ECK Associates Corp now owns 2,590 shares of the company’s stock worth $72,000 after buying an additional 427 shares during the last quarter. Finally, Cornercap Investment Counsel Inc. increased its holdings in shares of Doximity by 3.2% in the second quarter. Cornercap Investment Counsel Inc. now owns 17,143 shares of the company’s stock worth $479,000 after acquiring an additional 537 shares in the last quarter. Institutional investors own 87.19% of the company’s stock.

About Doximity

Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.